HONSUN (NANTONG) CO., LTD (hereinafter referred to as “HONSUN”) is located in Nantong Economic and Technological Development Zone, Jiangsu Province. It was established in January 2005 and was transformed into a joint-stock company with a registered capital of RMB 92.5 million in November 2014. The company went public on the NEEQ on April 20, 2015 (Stock: HONSUN; Stock Code: 832278), entered the NEEQ Innovation Tier in June 2016 and became one of the first companies to enter the NEEQ Select Tier and issue stocks publicly on July 27, 2020.
HONSUN specializes in R & D, design, production and sale of healthcare products for blood pressure testing, nebulizer treatments, home healthcare, body temperature testing, and clinical diagnosis etc. These products have been exported to many countries and regions in Europe, Asia, America, Africa and Oceania.
Based on strong R & D capacity and technical expertise, HONSUN has made remarkable achievements. In 2011, it was named as a high-tech enterprise. SCIAN Blood Pressure Monitor, a brand owned by HONSUN, was named as a famous product of Jiangsu Province in 2013. Two years later, SCIAN was recognized as a famous trademark of Jiangsu Province. In 2019, HONSUN was named to a specialized, refined, characteristic and innovative “Little Giant” of Jiangsu Province. As of the end of 2019, the company has applied for more than 100 patents and has passed a number of international certifications such as FDA, 510 (K), ISO13485, CE, ESH, SA8000, and BIHS. Besides, it has established a provincial-level engineering technology center. The automated production of diaphragm pressure sensor was approved of a National Torch Project and the electronic stethoscope was granted the Excellent Chinese Patent Award.
Founded in 2005
Covers an area of 50,000 m²
More than 600 employees
More than 100 patent applications